Literature DB >> 21475229

Alum's adjuvant action: grease is the word.

M Lamine Mbow, Ennio De Gregorio, Jeffrey B Ulmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475229     DOI: 10.1038/nm0411-415

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  INSOLUBLE PRECIPITATES IN DIPHTHERIA AND TETANUS IMMUNIZATION.

Authors:  A T Glenny
Journal:  Br Med J       Date:  1930-08-16

2.  Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

Authors:  Garry L Morefield; Anna Sokolovska; Dongping Jiang; Harm HogenEsch; J Paul Robinson; Stanley L Hem
Journal:  Vaccine       Date:  2005-02-18       Impact factor: 3.641

3.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

Review 4.  The path to a successful vaccine adjuvant--'the long and winding road'.

Authors:  Derek T O'Hagan; Ennio De Gregorio
Journal:  Drug Discov Today       Date:  2009-03-05       Impact factor: 7.851

5.  Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.

Authors:  Mirjam Kool; Virginie Pétrilli; Thibaut De Smedt; Aline Rolaz; Hamida Hammad; Menno van Nimwegen; Ingrid M Bergen; Rosa Castillo; Bart N Lambrecht; Jürg Tschopp
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.

Authors:  Tracy L Flach; Gilbert Ng; Aswin Hari; Melanie D Desrosiers; Ping Zhang; Sandra M Ward; Mark E Seamone; Akosua Vilaysane; Ashley D Mucsi; Yin Fong; Elmar Prenner; Chang Chun Ling; Jurg Tschopp; Daniel A Muruve; Matthias W Amrein; Yan Shi
Journal:  Nat Med       Date:  2011-03-13       Impact factor: 53.440

7.  The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity.

Authors:  Luigi Franchi; Gabriel Núñez
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

8.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

9.  Towards an understanding of the adjuvant action of aluminium.

Authors:  Philippa Marrack; Amy S McKee; Michael W Munks
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

10.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

Authors:  Stephanie C Eisenbarth; Oscar R Colegio; William O'Connor; Fayyaz S Sutterwala; Richard A Flavell
Journal:  Nature       Date:  2008-05-21       Impact factor: 49.962

  10 in total
  12 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 2.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

Review 3.  Adjuvants and lymphoma risk as part of the ASIA spectrum.

Authors:  Dana Butnaru; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates.

Authors:  Jing Wang; Nancy Tricoche; Lanying Du; Meredith Hunter; Bin Zhan; Gaddam Goud; Elizabeth S Didier; Jing Liu; Lu Lu; Preston A Marx; Shibo Jiang; Sara Lustigman
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

Review 5.  Cyclic di-nucleotides: new era for small molecules as adjuvants.

Authors:  Rimma Libanova; Pablo D Becker; Carlos A Guzmán
Journal:  Microb Biotechnol       Date:  2011-09-29       Impact factor: 5.813

6.  Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.

Authors:  Cecilia Buonsanti; Cristiana Balocchi; Carole Harfouche; Federica Corrente; Luisa Galli Stampino; Francesca Mancini; Marta Tontini; Padma Malyala; Simone Bufali; Barbara Baudner; Ennio De Gregorio; Nicholas M Valiante; Derek T O'Hagan; Rino Rappuoli; Ugo D'Oro
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

Review 7.  Protein bio-corona: critical issue in immune nanotoxicology.

Authors:  Monica Neagu; Zoi Piperigkou; Konstantina Karamanou; Ayse Basak Engin; Anca Oana Docea; Carolina Constantin; Carolina Negrei; Dragana Nikitovic; Aristidis Tsatsakis
Journal:  Arch Toxicol       Date:  2016-07-20       Impact factor: 5.153

8.  Phytol-derived novel isoprenoid immunostimulants.

Authors:  Roshni Roy Chowdhury; Swapan K Ghosh
Journal:  Front Immunol       Date:  2012-03-22       Impact factor: 7.561

9.  IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.

Authors:  Nicos Karasavvas; Chitraporn Karnasuta; Hathairat Savadsuk; Sirinan Madnote; Dutsadee Inthawong; Somsak Chantakulkij; Surawach Rittiroongrad; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Vinai Siriyanon; Charla A Andrews; Susan W Barnett; James Tartaglia; Faruk Sinangil; Donald P Francis; Merlin L Robb; Nelson L Michael; Viseth Ngauy; Mark S de Souza; Robert M Paris; Jean-Louis Excler; Jerome H Kim; Robert J O'Connell
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-09       Impact factor: 2.205

Review 10.  Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.

Authors:  Saborni Chattopadhyay; Jui-Yi Chen; Hui-Wen Chen; Che-Ming Jack Hu
Journal:  Nanotheranostics       Date:  2017-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.